NEOM
↗Tabuk, Saudi Arabia
NEOM is a $500 billion 'giga-project' and special economic zone in northwest Saudi Arabia, serving as a cornerstone of the Saudi Vision 2030 program. It is designed as a laboratory for the future, encompassing multiple regions including 'The Line' (a 170km linear city), 'Oxagon' (an advanced industrial hub), and 'Trojena' (a mountain tourism destination). The project is entirely powered by renewable energy and operates under its own independent legal and regulatory framework.
NEOM's Health, Well-Being & Biotech sector is a major pillar, aiming to build a world-class ecosystem focused on '4P' healthcare: Personalized, Predictive, Proactive, and Preventative. This sector integrates advanced genomics, digital twins, and AI-driven diagnostics to shift the focus from reactive treatment to proactive wellness. It serves as a global hub for biotech innovation, biomanufacturing, and clinical research.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Genomics, Digital Health, and Biomanufacturing
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$1B-$10B (Estimated project-related revenue)
Founded:2017
Ownership:government
Status:operating
FUNDING
Stage:Government Funded / Debt
Total Raised:$500B+
Investors:Public Investment Fund (PIF) of Saudi Arabia
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Ecosystem/Infrastructure focus)
Modalities:Cell therapy, Gene therapy, Brain-Computer Interface (BCI), Digital Twins, Personalized Pharmacology
Active Trials:2
Trial Phases:Phase 1: 1 | Phase 2: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Public Investment Fund (PIF)
Subsidiaries:ENOWA (Energy & Water), TONOMUS (Tech & Digital), Topian (Food), NEOM Green Hydrogen Company
Key Partnerships:WuXi AppTec (Biotech CRDMO localization), Paradromics (Brain-Computer Interface Center of Excellence), Oracle (Cloud infrastructure), McLaren Racing (Research and innovation)
COMPETITION
Position:Emerging
Competitors:Masdar City, Boston Biotech Hub, Singapore Biopolis
LEADERSHIP
Key Executives:
Aiman Al-Mudaifer - CEO
Dr. Mahmoud Alyamany - Head of Health, Well-Being & Biotech
Board Members:HRH Mohammed bin Salman (Chairman)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with NEOM. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.